Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 1875 for “"Cancer Therapy"”.

  1. Lactobacillus in cancer therapy

    Colon cancer is the second most common cancer in developed countries, as well as in Singapore. This study demonstrated that both Lactobacillus rhamnosus strain GG (LGG) and Lactobacillus casei strain Shirota (LcS) but not Lactobacillus bulgaricus (control bacteria) exerted specific dose dependent …

    nus Repository record for Lactobacillus in cancer therapy (opens in a new tab) Download file for Lactobacillus in cancer therapy (opens in a new tab)

  2. Azoreductases in cancer therapy.

    the-open-u

  3. THERMOGELLING POLYMERS FOR CANCER THERAPY

    … drug release and cell uptake studies of anti-cancer drugs, the thermogels are promising drug reservoir for sustainable release of payloads. In vivo anti-tumor evaluation on mice model of hepatocellular carcinoma further demonstrates significant inhibition on tumor growth using our materials, …

    nus Repository record for THERMOGELLING POLYMERS FOR CANCER THERAPY (opens in a new tab) Download file for THERMOGELLING POLYMERS FOR CANCER THERAPY (opens in a new tab)

  4. Carbon Nanotubes in Cancer Therapy

    … living systems specifically for applications in cancer therapy. Two main types of CNTs; single-walled (SWNT) and multi-walled (MWNT) have been investigated. Pristine CNTs are poorly soluble in aqueous solvents, and therefore need to be functionalized (f-CNT) to enhance their solubility and …

    cent-lancashire Download PDF for Carbon Nanotubes in Cancer Therapy (opens in a new tab)

  5. Radiosensitizing Nanoparticles for Cancer Therapy

    … from rare earth oxides as radiosensitizers in cancer therapy. While radiation therapy is the standard of care for treating many tumors found within the body, radiation toxicity can occur in healthy tissue as radiation travels through the body to reach the tumor. By selectively increasing the …

    rice Repository record for Radiosensitizing Nanoparticles for Cancer Therapy (opens in a new tab)

  6. Multifunctional Nanocarriers for Cancer Therapy

    Cancer is one of the leading causes of human mortality and mortality in all diseases. There has been a boost in developing nanocarrier-based therapies for treating cancer or other diseases during the past decade. One of the major advantages about nanocarrier (with the size range from 1-1000 nm) …

    south-carolina Repository record for Multifunctional Nanocarriers for Cancer Therapy (opens in a new tab)

  7. Multifunctional Nanoparticles for Cancer Therapy

    The relapse of cancer after first line therapy with anticancer agents is a common occurrence. This recurrence is generally accepted to be due to the presence of a small subpopulation of cells called cancer stem cells. Thus, it is essential to use a combination therapy consisting of at least one …

    creighton Repository record for Multifunctional Nanoparticles for Cancer Therapy (opens in a new tab)

  8. pH-Responsive Nanocarriers for Cancer Therapy

    … several strategies that are used to treat cancer including surgery, chemotherapy and radiotherapy. However, conventional chemotherapeutics suffer from a number of limitations, such as poor solubility, short <i>in vivo</i> circulation half-life and lack of specificity. To address these …

    the-open-u Download PDF for pH-Responsive Nanocarriers for Cancer Therapy (opens in a new tab)

  9. Novel embolic particles for cancer therapy

    … was to develop novel embolic particles for cancer therapy using a combination of nano and microparticles. The particles have been designed and synthesised to have a polystyrene core, be radiopaque, act as a radiosensitiser and have a high capacity for loading of chemotherapy drugs. </p> …

    oxford Repository record for Novel embolic particles for cancer therapy (opens in a new tab)

  10. Modified-Release Formulations for Cancer Therapy

    Cancer is one of the most virulent diseases in modern times that is ranked as the secondleading cause of death worldwide. The conventional and modern treatment protocols (e.g. chemotherapy and immunotherapy) for cancer still have some drawbacks that range from mild adverse effects to limited …

    ku Repository record for Modified-Release Formulations for Cancer Therapy (opens in a new tab)

  11. Carbon Nanomaterials for Catalytic Cancer Therapy

    Cancer poses a persistent global health challenge which demands more efficient treatments. Among various cancer treatment strategies, catalytic therapy, encompassing both chemotherapy and phototherapy, stands out due to its non-invasiveness and capacity to selectively target cancer cells. Catalytic …

    unsw Repository record for Carbon Nanomaterials for Catalytic Cancer Therapy (opens in a new tab)

  12. Immune Mechanisms of Microbial Cancer Therapy

    … and their presence within tumours is linked with cancer growth and poorer prognosis. However, this view oversimplifies their relationship with tumours, as recent research suggests that neutrophils also have anti-tumour properties. In addition, neutrophils possess considerable functional …

    unsw Repository record for Immune Mechanisms of Microbial Cancer Therapy (opens in a new tab)

  13. Endosomolytic Biomaterial Vaccines for Cancer Therapy

    … VIPER as a platform technology for delivery of cancer vaccines. Because the bioactivities of tumor antigens and vaccine adjuvants may be augmented by VIPER’s membrane-lytic properties, VIPER-mediated delivery of vaccine components to immune cell populations may potentiate anticancer immune …

    washington Repository record for Endosomolytic Biomaterial Vaccines for Cancer Therapy (opens in a new tab)

  14. ADRM1 AS A TARGET FOR CANCER THERAPY

    Ovarian cancer remains a highly lethal malignancy that is often diagnosed at an advanced stage, underscoring the need to uncover new therapeutic vulnerabilities for targeted drug development. ADRM1 is a ubiquitin receptor with the 19S regulatory particle of the proteasome. The ADRM1 gene is …

    jhu Repository record for ADRM1 AS A TARGET FOR CANCER THERAPY (opens in a new tab)

  15. MANABODIES: TCR-MIMIC ANTIBODIES FOR CANCER THERAPY

    A major challenge in developing new cancer therapies is specifically killing cancer cells without harming normal tissues. Mutations in the cancer cell are a key distinguishing feature of cancer, however most mutant proteins are intracellular and thus not accessible to traditional targeted …

    jhu Repository record for MANABODIES: TCR-MIMIC ANTIBODIES FOR CANCER THERAPY (opens in a new tab)

  16. Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy

    A rising trend in lung cancer chemotherapy involves the development of agents that exploit molecular targets overexpressed in tumors, with hopes of increasing specificity, and in turn, efficacy. β-Lapachone (β-lap) is a novel anticancer drug whose mechanism of action relies on its bioactivation by …

    utswmed Repository record for Beta-Lapachone Nanotherapeutics for Lung Cancer Therapy (opens in a new tab)

Page 1 of 94